Clinical Trials Directory

Trials / Completed

CompletedNCT01043419

Sympathetic Neural Outflow During Xenon Anesthesia in Humans

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Air Liquide Santé International · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test the hypothesis that sympathetic neural outflow to muscles as well as a sympathetic baroreflexes are not altered during xenon anesthesia in Healthy Volunteers.

Detailed description

Objectives for this study : * Main Objective : Influence of Xenon anesthesia on Sympathetic Nervous Activity * Secondary Objectives : Security under LENOXe™ (xénon 100 % v/v) anesthesia

Conditions

Interventions

TypeNameDescription
DRUGxenonInhalational gas; dose allowed max.70 Vol.% in 30 % oxygen; the duration of the treatment will be to 30 minutes

Timeline

Start date
2010-01-01
Primary completion
2010-03-01
Completion
2010-03-01
First posted
2010-01-06
Last updated
2025-09-11

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01043419. Inclusion in this directory is not an endorsement.

Sympathetic Neural Outflow During Xenon Anesthesia in Humans (NCT01043419) · Clinical Trials Directory